Amber Quant Lab research
Overview / Strategies
Strategies

Every strategy tested

Research candidates and the baselines they're measured against. Click any column to sort; click a strategy for the full write-up.

Research candidates

Proposed and built by the agent team.

StrategyVerdictVal. SharpeVal. CAGRVal. max DDCorr. 60/40DSRCycle2007–21
macro quadrant
Growth x inflation quadrant allocation from point-in-time hard data and breakevens
Needs work1.119.5%-9.6%0.22100%Oct 16, 2026
fear vs fundamentals
Fade market growth scares that the physical economy does not confirm
Needs work0.473.3%-9.3%0.3587%Oct 16, 2026
labor turn duration
Labor-turn duration timing: buy Treasuries when the labor market cracks, because the Fed cuts more than markets price
Rejected0.383.4%-16.1%-0.2182%Oct 16, 2026

Baselines

Reference strategies with textbook parameters.

StrategyVerdictVal. SharpeVal. CAGRVal. max DDCorr. 60/40DSR2007–21
60/40 stocks/bonds
benchmark
Baseline1.0911.9%-18.9%1.0099%
Macro regime (credit spreads)
macro_regime
Baseline1.0514.6%-23.5%0.9799%
S&P 500 buy-and-hold
benchmark
Baseline0.9217.3%-33.7%0.9898%
Risk parity
risk_parity
Baseline0.779.1%-26.6%0.6596%
Asset rotation
rotation
Baseline0.749.7%-18.2%0.4596%
Trend following
trend
Baseline0.464.3%-15.0%0.4976%

Reading the numbers

Sharpe is return above cash per unit of volatility; above 1 on validation is strong, and above 1.5 on daily data is treated as a likely bug until proven otherwise. Max DD is the worst peak-to-trough loss. Corr. 60/40 shows how much an idea overlaps the classic portfolio: low is valuable. DSR (deflated Sharpe ratio) is the probability the true Sharpe is above zero after accounting for how many variants of the idea were tried.

All figures are backtests from 2007 to 2021, after trading costs. The 2022-to-today holdout is sealed and not shown anywhere on this site.